Overall, evidence suggests differences in absorption and retention between methylcobalamin and cyanocobalamin
There is no legal pathway under current FDA policy to obtain pharmaceutical-grade BPC-157 or PDA for human use through compounding in the United States
BeackSKongWHJungHSDoIHHanSKimHet alPhotodynamic Therapy of Melanoma Skin Cancer Using Carbon Dot Chlorin e6 Hyaluronate Conjugate
A 2021 review reported no toxicity in BPC-157 animal studies, with the LD1 not achieved, and noted prior use in ulcerative colitis and multiple sclerosis trials
It is useful in the treatment of neuritis, polyneuritis, neuralgia, neuropathies, sciatica, facial paralysis, anemia, etc